首页> 美国卫生研究院文献>other >Extended Therapy With Pegylated Interferon and Weight-Based Ribavirin for HCV-HIV Coinfected Patients

【2h】

Extended Therapy With Pegylated Interferon and Weight-Based Ribavirin for HCV-HIV Coinfected Patients

机译：用聚乙二醇化干扰素和重量基利巴韦林进行延长治疗用于HCV-HIV焦收患者

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

BackgroundIt is unknown whether extended treatment with pegylated interferon (PEG) and weight-based ribavirin (WBR) results in higher rates of sustained virologic response (SVR) among HCV-HIV coinfected patients compared with standard duration therapy.

机译：背景技术尚不清楚是否与标准持续时间疗法相比，与Pegymated干扰素（PEG）和基于重量基的利巴韦林（WBR）的延长治疗是导致HCV-HIV繁殖患者中持续的病毒学反应（SVR）的较高速率。

著录项

期刊名称 other
作者
Raymond T. Chung; Triin Umbleja; Jennifer Y. Chen; Janet W. Andersen; Adeel A. Butt; Kenneth E. Sherman;
展开▼
作者单位

展开▼
年(卷),期 -1(13),2
年度 -1
页码 70–82
总页数 21
原文格式 PDF
正文语种
中图分类
关键词
extended therapy HCV HIV weight-based ribavirin;

机译：扩展治疗;HCV;HIV;基于体重的利巴韦林;

相似文献

外文文献
中文文献
专利

1. Extended therapy with pegylated interferon and weight-based ribavirin for HCV-HIV coinfected patients [J] . ChungR.T., UmblejaT., ChenJ.Y., HIV clinical trials . 2012,第2期

机译：聚乙二醇干扰素和基于体重的利巴韦林联合治疗HCV-HIV合并感染的患者
2. Premature treatment discontinuation in HIV/HCV-coinfected patients receiving pegylated interferon plus weight-based ribavirin. [J] . Soriano V, Miralles C, Berdun MA, Antiviral therapy . 2007,第4期

机译：HIV / HCV合并感染的患者接受聚乙二醇干扰素加基于体重的利巴韦林过早终止治疗。
3. Sustained virological response and baseline predictors in HIV-HCV coinfected patients retreated with pegylated interferon and ribavirin after failing a previous interferon-based therapy: Systematic review and meta-analysis [J] . BassoM., ParisiS., MengoliC., HIV clinical trials . 2013,第4期

机译：在先前基于干扰素的治疗失败后，接受聚乙二醇干扰素和利巴韦林治疗的HIV-HCV合并感染患者的持续病毒学应答和基线预测指标：系统评价和荟萃分析
4. Studies of Therapy with Thymosin α 1 in Combination with Pegylated Interferon α2a and Ribavirin in Nonresponder Patients with Chronic Hepatitis C [C] . ROBERTO CAMERINI, ALESSIA CIANCIO, ALFONSO DE ROSA, International Symposiumn on Thymosins in Health and Disease; 20070321-24; Washington,DC(US) . 2007

机译：胸腺素α1联合聚乙二醇化干扰素α2a和利巴韦林治疗慢性丙型肝炎无反应者的研究
5. The meaning of adherence among veterans receiving pegylated interferon and ribavirin antiviral treatment for chronic hepatitis C. [D] . Phillips, Frances Hinshaw. 2011

机译：接受聚乙二醇干扰素和利巴韦林抗病毒治疗的慢性丙型肝炎退伍军人依从性的含义。
6. Impact of IL28B gene polymorphisms on interferon-λ3 plasma levels during pegylated interferon-α/ribavirin therapy for chronic hepatitis C in patients coinfected with HIV [O] . Norma I. Rallón, Vincent Soriano, Susanna Naggie, -1

机译：聚乙二醇化干扰素-α/利巴韦林治疗合并感染艾滋病毒的慢性丙型肝炎期间IL28B基因多态性对干扰素λ3血浆水平的影响
7. Extended Therapy With Pegylated Interferon and Weight-Based Ribavirin for HCV-HIV Coinfected Patients [O] . Raymond T. Chung, Triin Umbleja, Jennifer Y. Chen, 2012

机译：用聚乙二醇化干扰素和重量基利巴韦林进行延长治疗，用于HCV-HIV焦收患者

Extended Therapy With Pegylated Interferon and Weight-Based Ribavirin for HCV-HIV Coinfected Patients

摘要

著录项

相似文献

相关主题

期刊订阅